Search by Drug Name or NDC

    NDC 29978-0587-01 Aquanaz 15; 400; 10 mg/1; mg/1; mg/1 Details

    Aquanaz 15; 400; 10 mg/1; mg/1; mg/1

    Aquanaz is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Capital Pharmaceutical, LLC. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 29978-0587
    Product ID 29978-587_a0acddf1-a97e-bf37-e053-2995a90a0bd5
    Associated GPIs 43997303100314
    GCN Sequence Number 072784
    GCN Sequence Number Description guaifen/dextromethorphan/PE TABLET 400-15-10 ORAL
    HIC3 B4R
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-EXPECTORANT
    GCN 37072
    HICL Sequence Number 000216
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR/PHENYLEPHRINE
    Brand/Generic Brand
    Proprietary Name Aquanaz
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dextromethorphan Hydrobromide, Guaifenesin and Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 15; 400; 10
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Capital Pharmaceutical, LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2022-12-31

    Package

    NDC 29978-0587-01 (29978058701)

    NDC Package Code 29978-587-01
    Billing NDC 29978058701
    Package 100 TABLET in 1 BOTTLE (29978-587-01)
    Marketing Start Date 2015-03-10
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 5e9e4dfd-4def-4756-9bba-d25068640101 Details

    Revised: 3/2020